指南与共识消化、代谢与肾脏急症重症综合管理与镇静镇痛

EAES快速指南:复杂性憩室炎的手术治疗——ESCP参与制定

EAES rapid guideline: surgical management of complicated diverticulitis - with ESCP participation.
指南 / 共识 · Surg Endosc · 2024-12-28
一句话结论EAES指南建议:无脓毒症的复杂性憩室炎需手术者,在具备结直肠手术技能与经验的外科医生条件下,行一期吻合术而非Hartmann切除术或腹腔镜灌洗;脓毒症、衰弱、免疫抑制患者则建议Hartmann切除术。

EAES针对复杂性憩室炎手术治疗制定快速指南,由多学科小组基于个体参与者数据网络Meta分析(一期吻合术PRA vs Hartmann切除术HR vs 腹腔镜灌洗LPL),采用GRADE和CINeMA评估证据确定性,经证据到决策框架和改良Delphi调查达成共识。指南建议:无脓毒症且具备结直肠手术技能与经验的外科医生条件下,PRA优于HR或LPL;脓毒症、衰弱、免疫抑制患者亚组建议HR优于PRA或LPL。PRA的关键获益为1年时无造口可能性更高,各比较风险相似。推荐为条件性,强调共享决策。

要点

  • 无脓毒症的复杂性憩室炎需手术者,在具备结直肠手术技能与经验的外科医生条件下,建议行PRA而非HR或LPL(条件性推荐)。
  • 脓毒症、衰弱、免疫抑制患者亚组,建议行HR而非PRA或LPL(条件性推荐)。
  • PRA的关键获益为1年时无造口可能性更高,各比较风险相似。
  • 推荐为条件性,考虑管理选项时应共享决策。
  • 外科医生和患者应首先考虑有条件推荐的干预措施,然后考虑有条件不推荐的措施。

适用人群与场景

  • 有手术指征的复杂性憩室炎患者。
  • 亚组:脓毒症、衰弱、免疫抑制患者。

处置流程与药物剂量

  • 无脓毒症的复杂性憩室炎患者,在具备结直肠手术技能与经验的外科医生条件下,建议行一期吻合术(PRA)而非Hartmann切除术(HR)或腹腔镜灌洗(LPL)(条件性推荐)。
  • 脓毒症、衰弱、免疫抑制患者亚组,建议行Hartmann切除术(HR)而非PRA或LPL(条件性推荐)。
  • 外科医生和患者应首先考虑有条件推荐的干预措施,然后考虑有条件不推荐的措施;考虑管理选项时应共享决策。

研究设计与关键结果

  • 基于个体参与者数据网络Meta分析(PRA vs HR vs LPL),小组采用GRADE和CINeMA评估证据确定性,经证据到决策框架和改良Delphi调查达成共识。
  • PRA的关键获益为1年时无造口可能性更高,各比较风险相似。

证据类型、等级与局限

  • 证据类型:临床实践指南(EAES快速指南,ESCP参与制定),基于个体参与者数据网络Meta分析,采用GRADE和CINeMA评估证据确定性。
  • 推荐强度:条件性推荐。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 无脓毒症的复杂性憩室炎需手术者,在具备结直肠手术技能与经验的外科医生条件下,可考虑PRA而非HR或LPL(条件性推荐)。
  • 脓毒症、衰弱、免疫抑制患者亚组,可考虑HR而非PRA或LPL(条件性推荐)。
  • 推荐为条件性,应共享决策;外科医生和患者应首先考虑有条件推荐的干预措施,然后考虑有条件不推荐的措施。

指南或共识出处

  • EAES rapid guideline: surgical management of complicated diverticulitis - with ESCP participation(发表于Surg Endosc)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The surgical management of complicated diverticulitis varies across Europe. EAES members prioritized this topic to be addressed by a clinical practice guideline through an online questionnaire.

OBJECTIVE: To develop evidence-informed clinical practice recommendations for key stakeholders involved in the treatment of complicated diverticulitis; to improve operative and perioperative outcomes, patient experience and quality of life through a systematic evidence-to-decision approach by a diverse, multidisciplinary panel.

METHODS: Informed by a linked individual participant data network meta-analysis of resection and primary anastomosis (PRA) versus Hartmann's resection (HR) versus laparoscopic lavage (LPL), a panel of general and colorectal surgeons, patient partners, trialists, and fellows appraised the certainty of the evidence using GRADE and CINeMA. The panel discussed the evidence using the evidence-to-decision framework during a synchronous consensus meeting. An asynchronous modified Delphi survey was used to establish consensus.

RESULTS: The panel suggests that patients with complicated diverticulitis without sepsis receive PRA over HR or LPL when there is availability of a surgeon with skills and experience in colorectal surgery. HR is suggested over PRA or LPL in the subgroups of septic, frail, as well as immunocompromised patients. These recommendations apply to patients with an indication for surgery. Surgeons and patients should first consider conditionally recommended interventions, then conditionally recommended against. Based on the evidence, the key benefit of PRA was a higher likelihood of not having a stoma at 1 year, with similar risks across comparisons. Conditional recommendations call for shared decision-making when considering management options. The full guideline with user-friendly decision aids is available in https://app.magicapp.org/#/guideline/7490 .

CONCLUSION: This clinical practice guideline provides evidence-informed recommendations on the management of patients with complicated diverticulitis in accordance with the highest methodological standards through a structured framework informed by an international, multidisciplinary panel of stakeholders.

来源:Surg Endosc,查看原文。版权归原作者所有。

参考来源

  1. Antoniou SA, Huo B, Ortenzi M, et al. EAES rapid guideline: surgical management of complicated diverticulitis - with ESCP participation. Surg Endosc. 2024. PMID: 39733172. doi:10.1007/s00464-024-11445-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。